COVID-19: GP & LP perspectives on valuations The webinar will - PowerPoint PPT Presentation

Dec 27, 2022 •158 likes •219 views

COVID-19: GP & LP perspectives on valuations The webinar will begin shortly Please submit questions using the questions pane in the menu on the right of your screen BVCA Webinar | 05 May 2020 COVID-19: GP & LP perspectives on

COVID-19: GP & LP perspectives on valuations The webinar will begin shortly Please submit questions using the questions pane in the menu on the right of your screen BVCA Webinar | 05 May 2020
COVID-19: GP & LP perspectives on valuations Paul Cunningham Leon de Bono Geoffrey Geiger Helios Investment BVCA USS Partners and IPEV Sue Hunter Michael Mowlem Marc Puglia Frog Capital Sandaire Providence Equity BVCA Webinar | 05 May 2020
The panel Moderator Host Leon de Bono Geoffrey Geiger Assistant Director General, Head of Private Equity, BVCA USS Paul Cunningham Sue Hunter Chief Financial Officer, Non-Executive Partner, Helios Investment Partners, Frog Capital and Chairman, IPEV Marc Puglia Michael Mowlem Chief Financial Officer Managing Director, and Managing Director, Sandaire Providence Equity BVCA Webinar | 05 May 2020
COVID-19: GP & LP perspectives on valuations IPEV special Challenges Looking valuation for LPs forwards guidance Venture & Practical buyout applications differences BVCA Webinar | 05 May 2020
Join us this Thursday for COVID-19: the practicalities of the exit strategy BVCA Webinar | Thursday 7 May 2020 | 2pm Michael Moore Cheryl Potter BVCA Former BVCA Chair Gurpreet Manku Leon de Bono BVCA BVCA
Thank you Find further updates and guidance at bvca.co.uk/about-us/coronavirus-updates Find us on +44(0)20 7492 0400 / bvca@bvca.co.uk / www.bvca.co.uk

Download Presentation

Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

CO COVID ID-19 19 Where are we with COVID-19? What can you tell us about the CO COVID-19 19

CO COVID ID-19 19 Where are we with COVID-19? What can you tell us about the CO COVID-19 19 vaccine ine? COVID-19 in Arizona 182,203 cases overall Confirmed and probable A person is counted once, no matter how many tests

730 views • 56 slides

What we will cover: o Review of where we are with COVID-19 o Absolute Risk from COVID-19 o COVID

COVID-19 An Occupational Health Update 29 th July 2020 Dr Munna Roy , Medical Director , Integral OH What we will cover: o Review of where we are with COVID-19 o Absolute Risk from COVID-19 o COVID Age o Shielding Pause o Risk Assessment and

495 views • 23 slides

Florida COVID-19 Cases COVID-19 Cases Hillsborough COVID-19 Cases Orange COVID-19 Cases

Florida COVID-19 Cases COVID-19 Cases Hillsborough COVID-19 Cases Orange COVID-19 Cases Duval Suspended visitation and Developed 120 ambulance Deployed Rapid mandated staff screening assessment teams to Emergency Support Teams

394 views • 12 slides

1 Steps to Take Now to Prepare for COVID-19 Stay informed about COVID-19 by monitoring o CDC

Coronavirus COVID 19 Infection Prevention & Control: Getting to the Root Cause Pamela Truscott, MSN, RN, DNS-CT, QCP, RAC-CT Senior Manager, Clinical and Regulatory Services COVID-19 Questions email - COVID19@ahca.org 1 Background

354 views • 12 slides

COVID-19 in Italy Case Fatality Rate COVID-19 in Italy COVID-19 in Tuscany n/100.000 3 2

COVID-19 in Italy Case Fatality Rate COVID-19 in Italy COVID-19 in Tuscany n/100.000 3 2 1 Florence - total: 994 (0.26 %) COVID-19 in Italy COVID-19 in Italy: Severity ID/LF-ASD 1 General Population asymptomatic to mild: 81-49%

582 views • 30 slides

COVID-19 Virginia Department of Labor and Industry ABOUT CORONAVIRUS COVID-19 COVID-19 is an

COVID-19 Virginia Department of Labor and Industry ABOUT CORONAVIRUS COVID-19 COVID-19 is an infectious disease caused by the recently found virus known as SARS-CoV-2 (or coronavirus). Before the outbreak originated in Wuhan, China on

512 views • 25 slides

NIH and CDC Protocols and Causing More COVID Deaths than COVID Alone!!! If You Have COVID: Why

NIH and CDC Protocols and Causing More COVID Deaths than COVID Alone!!! If You Have COVID: Why You Should NOT go to a HOSPITAL, and what you should ASK for if you are admitted to a hospital and have tested Positive for COVID! How to Prevent

571 views • 12 slides

The impact of Covid-19 on cleared derivatives 23 April 2020 FIA engagement on COVID-19 with a

The impact of Covid-19 on cleared derivatives 23 April 2020 FIA engagement on COVID-19 with a focus on ensuring open and orderly markets Dedicated COVID-19 webpage (www.fia.org/covid-19) set up providing daily operational and regulatory

328 views • 21 slides

Guidance for Covid-2 AKA Hospitality (for the purposes of Covid) Know your enemy!

Village/Church Halls Guidance for Covid-2 AKA Hospitality (for the purposes of Covid) Know your enemy! Encapsulated virus Longevity on surfaces - Covid cannot grow on food Moves through human interaction

346 views • 11 slides

School Reentry and Advocacy Efforts in a COVID-19 Era COVID-19 CDC Resources COVID-19: CDC

School Reentry and Advocacy Efforts in a COVID-19 Era COVID-19 CDC Resources COVID-19: CDC Resources Latest COVID-19 information : www.cdc.gov/coronavirus COVID prevention:

458 views • 16 slides

Partnership Covid Summary 1. Impact of Covid-19 The virus Covid-19 hospital admissions (at 26 th

Community Planning Partnership Covid Summary 1. Impact of Covid-19 The virus Covid-19 hospital admissions (at 26 th May) ABC had the highest rate of hospitalisation 515 per 100,000 population COVID-19 Infection Rate by Sex, Deprivation and

431 views • 26 slides

CORONAVIRUS | COVID-19 CORONAVIRUS COVID-19 WHAT YOU NEED TO KNOW The Coronavirus has made

Creating a NO HARM culture for generations to come CORONAVIRUS | COVID-19 CORONAVIRUS COVID-19 WHAT YOU NEED TO KNOW The Coronavirus has made headlines around the world over the past few weeks after it was discovered in China. COVID-19 is

168 views • 12 slides

COVID-19: Update for NPs and PAs Learning Objectives Describe what is currently known about

COVID-19: Update for NPs and PAs Learning Objectives Describe what is currently known about COVID-19 epidemiology and transmission Assess current COVID-19 diagnostic strategies Discuss evolving therapeutic approaches to COVID-19

536 views • 43 slides

COVID-19: Update for NPs and PAs Learning Objectives Describe what is currently known about

963 views • 35 slides

O P P O R T U N I T Y D A Y P R E S E N T A T I O N Q 1 / 2 0 2 0 27. 02. 2020 N W N W

O P P O R T U N I T Y D A Y P R E S E N T A T I O N Q 1 / 2 0 2 0 27. 02. 2020 N W N W AGEND GENDA 1. BEFORE COVID - JAN FEB 2020 PERFORMANCE 2. COVID PANDEMIC - COVID-19 BUSINESS ADAPTATION 3. AFTER COVID - NEW NORMAL 1

907 views • 34 slides

COVID-19: Financial Impacts and Response Planning Responding to the COVID-19 Crisis COVID-19

COVID-19: Financial Impacts and Response Planning Responding to the COVID-19 Crisis COVID-19 presents a severe, prolonged crisis for Caltrain. The agency has responded to the initial crisis by adjusting service and has secured emergency

214 views • 17 slides

Professional responsibility and practice before the USPTO Office of Enrollment and Discipline

Professional responsibility and practice before the USPTO Office of Enrollment and Discipline United States Patent and Trademark Office Register of patent practitioners oedci.uspto.gov/OEDCI/ 3 Biennial registration statement Final rule

396 views • 35 slides

Professional responsibility and practice before the USPTO Office of Enrollment and Discipline

482 views • 31 slides

OWASP Daniel Brzozowski daniel@brzozowski.biz Agenda 1. Few words about OWASP 2. Owasp resources

OWASP Daniel Brzozowski daniel@brzozowski.biz Agenda 1. Few words about OWASP 2. Owasp resources 3. Setting up workstations 4. OWASP WebScarab/OWASP WebScarab-NG 5. O2 Platform About me In London since October 2010 Before that MCPD, MCTS,

747 views • 58 slides

Lattice study of gluon and ghost propagators in Landau gauge QCD E.M. Ilgenfritz

Lattice study of gluon and ghost propagators in Landau gauge QCD E.M. Ilgenfritz Collaborators in Landau gauge lattice QCD: R. Aouane 1 1 HU Berlin Support by: I. L. Bogolubsky 2 2 JINR Dubna V. G. Bornyakov 3 , 4 3 ITEP Moscow F. Burger 1 4

666 views • 48 slides

Mu2e Jason Bono on behalf of the Mu2e Collaboration Fermilab Users Meeting June 16, 2016

Mu2e Jason Bono on behalf of the Mu2e Collaboration Fermilab Users Meeting June 16, 2016 PREFACE Mu2e Mu2e will search for N eN with unprecedented sensitivity, (10 -17 ) e conversion is Charged Lepton Flavor

690 views • 52 slides

Schooling and Labour Market Impacts of Bolivias Bono Juancito Pinto Carla Canelas 1 ua 2

Schooling and Labour Market Impacts of Bolivias Bono Juancito Pinto Carla Canelas 1 ua 2 Miguel Ni no-Zaraz Public Economics for Development Maputo, 2017 1 University of Sussex 2 UNU-WIDER. 1 Bolivias Social Protection System

476 views • 20 slides

Optimizing Trajectories for Detection at Crossing . . . Unmanned Aerial Vehicles Strategy

Patrolling the Border: . . . How to Describe . . . Constraints on . . . Simplification of the . . . Optimizing Trajectories for Detection at Crossing . . . Unmanned Aerial Vehicles Strategy Selected by . . . Towards an Optimal . . . (UAVs)

394 views • 13 slides

bdrmap-IT: Mapping AS Borders in the Internet Alex Marder , Matthew Luckie, Amogh Dhamdhere,

bdrmap-IT: Mapping AS Borders in the Internet Alex Marder , Matthew Luckie, Amogh Dhamdhere, Bradley Huffaker, kc claffy, and Jonathan M. Smith Problem How do we infer router operators and interdomain links from a traceroute dataset?

526 views • 14 slides